BNP Paribas Asset Management
SAGE

BNP Paribas Asset Management’s Sage Therapeutics SAGE Stock Holding History

BNP Paribas Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-187,284
Closed -$13.5M – 822
2019
Q4 		$13.5M Buy
187,284
+125,534
+203% +$15.4M 0.09% 263
2019
Q3 		$8.66M Sell
61,750
-38,789
-39% -$6.49M 0.07% 325
2019
Q2 		$18.4M Sell
100,539
-26,274
-21% -$4.48M 0.15% 185
2019
Q1 		$20.2M Buy
126,813
+2,984
+2% +$432K 0.17% 171
2018
Q4 		$11M Buy
123,829
+35,244
+40% +$4.03M 0.1% 273
2018
Q3 		$12.5M Buy
88,585
+14,486
+20% +$2.24M 0.1% 287
2018
Q2 		$11.6M Buy
+74,099
New +$11.6M 0.1% 303

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return